The accelerator is open to international startups for the first time, making it accessible to Nigeria-based ventures. The healthtech focus aligns with the e-pharmacy platform, and the founder's regulatory expertise is a strong asset. However, details on funding amount and deadlines are not provided, so fit is moderate.